Hisamitsu Pharmaceutical Co Inc operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hisamitsu Pharmaceutical Co Inc with three other
companies in this sector in Japan:
Daito Pharmaceutical Company Limited
sales of 39.88 billion Japanese Yen [US$360.88 million]
of which 52%
was Drug Substance),
Moriroku Holdings Co Ltd
(182.18 billion Japanese Yen [US$1.65 billion]
of which 63%
was Resin processing products business), and
Kissei Pharmaceutical Company Limited
(74.01 billion Japanese Yen [US$669.78 million]
of which 86%
was Pharmaceutical Products).
Hisamitsu Pharmaceutical Co Inc reported sales of ¥147.87 billion (US$1.34 billion)
February of 2018.
a very small
increase of 1.3%
versus 2017, when the company's sales were ¥145.93 billion.
Despite this increase, sales are still
below the level achieved in 2016, when Hisamitsu Pharmaceutical Co Inc
reported sales of ¥161.85 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Hisamitsu Pharmaceutical Co Inc had sales
of ¥142.77 billion.